Low rates of nucleoside reverse transcriptase inhibitor and nonnucleoside reverse transcriptase inhibitor drug resistance in Botswana

BACKGROUND: Scale-up of antiretroviral therapy (ART) and introduction of treat-all strategy necessitates population-level monitoring of acquired HIV drug resistance (ADR) and pretreatment drug resistance (PDR) mutations. METHODS: Blood samples were collected from 4973 HIV-positive individuals residi...

Descripción completa

Detalles Bibliográficos
Autores principales: Moyo, Sikhulile, Gaseitsiwe, Simani, Zahralban-Steele, Melissa, Maruapula, Dorcas, Nkhisang, Tapiwa, Mokaleng, Baitshepi, Mohammed, Terence, Ditlhako, Tsotlhe R., Bareng, Ontlametse T., Mokgethi, Thatayaone P., van Widenfelt, Erik, Pretorius-Holme, Molly, Mine, Madisa O., Raizes, Elliot, Yankinda, Etienne Kadima, Wirth, Kathleen E., Gaolathe, Tendani, Makhema, Joseph M., Lockman, Shahin, Essex, Max, Novitsky, Vlad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Epidemiology and Social
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467559/
https://www.ncbi.nlm.nih.gov/pubmed/30946161
http://dx.doi.org/10.1097/QAD.0000000000002166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467559/
https://www.ncbi.nlm.nih.gov/pubmed/30946161
http://dx.doi.org/10.1097/QAD.0000000000002166

Ejemplares similares